Table 4.
Subsequent analysis of clinical samples of 20 patients with initial RT-PCR-positive nasopharyngeal aspirates and antibody seroconversion to SARS-associated coronavirus
| Time after onset of symptoms (days; n=20) | |||||
|---|---|---|---|---|---|
| 10 | 13 | 16 | 19 | 21 | |
| Sample (positivity rate) | |||||
| Nasopharyngeal aspirate | 19 (95%) | 18 (90%) | 18 (90%) | 15 (75%) | 9 (47%)* | 
| Stool | 20 (100%) | 20 (100%) | 19 (95%) | 12 (80%)† | 10 (67%)† | 
| Urine | 10 (50%) | 9 (45%) | 7 (35%) | 6 (30%) | 4 (21%)* | 
in 19 patients.
In 15 patients